கார்னியல் ஆரோக்கியம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from கார்னியல் ஆரோக்கியம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In கார்னியல் ஆரோக்கியம் Today - Breaking & Trending Today

Glaukos Corp (GKOS) Q2 2021 Earnings Call Transcript

Glaukos Corp (GKOS) Q2 2021 Earnings Call Transcript
fool.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fool.com Daily Mail and Mail on Sunday newspapers.

United States , New Zealand , Matt Obrien , Allen Gong Jpmorgan , Chrism Calcaterra , Preserflo Microshunt , Chris Calcaterra , Andrew Brackmann , Robbie Marcus , Asia Pacific , Chris Cooley Stephens , Andrew Brackmann Blair , John Block , Thomasw Burns , Stafford Piper Sandler , Josephe Gilliam , Piper Sandler , Joe Gilliam , Chris Cooley , Tom Burns , Glaukos Corp , Surgery Center Association , Corneal Health , Welcome To Glaukos Corporation Second Quarter , American Glaucoma Society , American Academy Of Ophthalmology ,

Glaukos Corp (GKOS) Q2 2021 Earnings Call Transcript

Glaukos Corp (GKOS) Q2 2021 Earnings Call Transcript
msn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from msn.com Daily Mail and Mail on Sunday newspapers.

United States , New Zealand , Matt Obrien , Ravi Misra , Allen Gong Jpmorgan , Chrism Calcaterra , Preserflo Microshunt , Chris Calcaterra , Andrew Brackmann , Robbie Marcus , Anthony Petrone Jefferies , Asia Pacific , Chris Cooley Stephens , Anthony Citi , Andrew Brackmann Blair , John Block , Thomasw Burns , Josephe Gilliam , Stafford Piper Sandler , Joe Gilliam , Ravi Misra Berenberg , Piper Sandler , Steve Litchman , Chris Cooley , Tom Burns , David Kuang Oppenheimer ,

Glaukos Corporation : Announces First Quarter 2021 Financial Results

Glaukos Corporation , an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced. | May 5, 2021 ....

United States , Thomas Burns , Glaukos Corporation , Exchange Commission , Avedro Inc , Corneal Health , Micro Invasive Glaucoma Surgery , Annual Report , Quarterly Report , Investor Section , Regarding Use , Generally Accepted Accounting Principles , Glaukos Corporation Stock Exchange , Press Release , Oday Gkos Us3773221029 , ஒன்றுபட்டது மாநிலங்களில் , தாமஸ் தீக்காயங்கள் , பரிமாற்றம் தரகு , கார்னியல் ஆரோக்கியம் , மைக்ரோ ஆக்கிரமிப்பு கிள La கோமா அறுவை சிகிச்சை , ஆண்டு அறிக்கை , காலாண்டு அறிக்கை , முதலீட்டாளர் பிரிவு , தொடர்பாக பயன்பாடு ,

Glaukos Corporation Announces First Quarter 2021 Financial Results

Search jobs
Glaukos Corporation Announces First Quarter 2021 Financial Results
SAN CLEMENTE, Calif. (BUSINESS WIRE) Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced financial results for the first quarter ended March 31, 2021. Key highlights include:
Net sales growth of 23% to $68.0 million in Q1 2021, compared to $55.3 million in Q1 2020.
Glaucoma net sales of $53.7 million and Corneal Health net sales of $14.3 million in Q1 2021.
Gross margin of approximately 76% and non-GAAP gross margin of approximately 84% in Q1 2021.
Operating expenses of $63.1 million and non-GAAP operating expenses of $61.8 million in Q1 2021. ....

United States , Chris Lewis , Thomas Burns , Corporate Strategy Development , Glaukos Corporation , Exchange Commission , Avedro Inc , Corneal Health , Micro Invasive Glaucoma Surgery , Annual Report , Quarterly Report , Investor Section , Regarding Use , Generally Accepted Accounting Principles , Investor Relations , Corporate Strategy , ஒன்றுபட்டது மாநிலங்களில் , கிறிஸ் லெவிஸ் , தாமஸ் தீக்காயங்கள் , பெருநிறுவன மூலோபாயம் வளர்ச்சி , பரிமாற்றம் தரகு , கார்னியல் ஆரோக்கியம் , மைக்ரோ ஆக்கிரமிப்பு கிள La கோமா அறுவை சிகிச்சை , ஆண்டு அறிக்கை , காலாண்டு அறிக்கை , முதலீட்டாளர் பிரிவு ,

Glaukos Corp (GKOS) Q4 2020 Earnings Call Transcript

Operator
Welcome to Glaukos Corporation s Fourth Quarter and Full Year 2020 Financial Results Conference Call. A copy of the company s press release issued after the market close today is available at www.glaukos.com. [Operator Instructions] This call is being recorded and archived replay will be available online in the Investor Relations section at www.glaukos.com.
I will now turn the call over to Chris Lewis, Director of Investor Relations and Corporate Strategy and Development.
Chris Lewis
Director of Investor Relations and Corporate Strategy and Development
Thank you, and good afternoon. Joining me today are Glaukos President and CEO, Tom Burns; CFO, Joe Gilliam; and COO, Chris Calcaterra. [Operator Instructions] Please note that all statements other than statements of historical facts made on this call that address activities, events or developments we expect, believe, or anticipate, will or may occur in the future are forward-looking statements. These ....

United States , Chris Calcaterra , Chris Lewis , Andrew Brackmann William Blair , Andrew Brackmann , Robbie Marcus , Ravi Masri , Anthony Petrone Jefferies , Chris Cooley Stephens , Matt Obrien Piper Sandler , Andrew Stafford Piper Sandler , Thomasw Burns , Josephe Gilliam , Ravi Masri Berenberg , Joe Gilliam , Chris Cooley , Tom Burns , Steven Lichtman , K Gong Jpmorgan , William Blair , Anthony Petrone , Glaukos Corp , Steven Lichtman Oppenheimer Company Analyst , Corneal Health , Glaukos Corporation , Corporate Development ,